Muscle Cell News Volume 7.36 | Oct 24 2022

    0
    29







    2022-10-24 | MUSCN 7.36


    Muscle Cell News by STEMCELL Technologies
    Vol. 7.36 – 24 October, 2022
    TOP STORY

    Pyruvate Dehydrogenase Kinase 4 Promotes Ubiquitin–Proteasome System-Dependent Muscle Atrophy

    Researchers investigated and delineated the role of pyruvate dehydrogenase kinase 4 in the context of muscle atrophy, which could be identified as a potential therapeutic avenue to protect against dexamethasone-induced muscle wasting.
    [Journal of Cachexia Sarcopenia and Muscle]

    Full Article
    Activate, expand, and differentiate your cells with cytokines, chemokines, and growth factors from STEMCELL Technologies.
    PUBLICATIONSRanked by the impact factor of the journal

    E3 Ubiquitin Ligase RNF5 Attenuates Pathological Cardiac Hypertrophy through STING

    Researchers found that ring-finger protein 5 (RNF5) expression was upregulated in animal and cellular models of cardiac hypertrophy.
    [Cell Death & Disease]

    Full Article

    Fibrin-Based Cardiac Patch Containing Neuregulin-1 for Heart Repair after Myocardial Infarction

    A fibrin-based cardiac patch loaded with neuregulin-1 (NRG-1) was developed to attach locally to the infarct area of the heart and exhibited good biocompatibility and promoted cardiomyocyte proliferation in vitro via NRG-1/ErbB signaling.
    [Colloids and Surfaces B-Biointerfaces]

    AbstractGraphical Abstract

    Decrotonylation of AKT1 Promotes AKT1 Phosphorylation and Activation during Myogenic Differentiation

    Investigators highlighted the important role of decrotonylation of AKT serine/threonine kinase 1 (AKT1) in the process of muscle differentiation, where it aided the phosphorylation and activation of AKT1 and promoted myogenic differentiation.
    [Journal of Advanced Research]

    Full ArticleGraphical Abstract

    Temporal Analysis of Skeletal Muscle Remodeling Post Hindlimb Ischemia Reveals Intricate Autophagy Regulation

    Scientists studied whether perturbations in the molecular catabolic-autophagy signaling network were linked to the temporal remodeling of skeletal muscle in hind limb ischemia.
    [American Journal of Physiology-Cell Physiology]

    Abstract

    Angiogenic Stem Cell Delivery Platform to Augment Post-Infarction Neovasculature and Reverse Ventricular Remodeling

    Researchers demonstrated joint delivery of human-derived endothelial progenitor cells and smooth muscle cells as a scaffold-free, bi-level cell sheet platform to improve ventricular remodeling and function in an athymic rat model of myocardial infarction.
    [Scientific Reports]

    Full Article

    Exosomes Derived from Bone Marrow Mesenchymal Stem Cells Inhibit Human Aortic Vascular Smooth Muscle Cells Calcification via the miR-15a/15b/16/NFATc3/OCN Axis

    Investigators utilized human aortic vascular smooth muscle cells stimulated by high phosphate to investigate how bone marrow mesenchymal stem cell-derived exosomes relieve vascular calcification.
    [Biochemical and Biophysical Research Communications]

    Full ArticleGraphical Abstract

    Downregulation of Natriuretic Peptide Receptor-C in Vascular Smooth Muscle Cells from Spontaneously Hypertensive Rats Contributes to Vascular Remodeling

    Scientists investigated the relationship between the decreased expression of natriuretic peptide receptor-C and vascular remodeling in spontaneously hypertensive rats and the underlying molecular mechanisms.
    [Peptides]

    Abstract
    Explore tools and resources for your return to the lab
    REVIEWS

    Exosomes: Mediators Regulating the Phenotypic Transition of Vascular Smooth Muscle Cells in Atherosclerosis

    Investigators use vascular smooth muscle cell phenotypic transition in atherosclerosis (AS) to introduce the effect of exosomes on AS from different perspectives and discuss the status quo, deficiencies, and potential future directions to provide new ideas for clinical research and treatment.
    [Cell Communication and Signaling]

    Full Article

    The Regenerative Potential of Pax3/Pax7 on Skeletal Muscle Injury

    The authors provide a review of the application of Pax3/Pax7 factors as well as the mechanism and value of this protein innovation on gene regeneration and compare it with previous treatments.
    [The Journal of Genetic Engineering and Biotechnology]

    Full Article
    INDUSTRY AND POLICY NEWS

    Biogen Announces FDA’s Three-Month Extension of Review Period for the New Drug Application for Tofersen

    Biogen Inc. announced that the FDA has extended the review period of the new drug application for tofersen by three months. Tofersen is an investigational treatment for superoxide dismutase amyotrophic lateral sclerosis.
    [Biogen, Inc.]

    Press Release

    Solid Biosciences Reports Additional Preclinical Data Demonstrating that its Novel Capsid, AAV-SLB101, Provides Superior Transduction Efficiency and Enhanced Distribution to Skeletal Muscle

    Solid Biosciences presented additional data characterizing AAV-SLB101, a novel adeno-associated virus vector designed for improved transduction efficiency and biodistribution to muscle cells.
    [Solid Biosciences]

    Press Release
    FEATURED EVENT

    AACR Special Conference: Cancer Metastasis

    November 14 – 17, 2022
    Portland, Oregon, United States

    > See All Events

    JOB OPPORTUNITIES

    PhD Scholarship – Vascular Smooth Muscle Cell Aging

    University of East Anglia – Norwich, United Kingdom

    Postdoctoral Researcher – Experimental Muscle

    University of London – Royal Veterinary College – London, United Kingdom

    Postdoctoral – Striated Muscle Diseases

    Karolinska Institute – Stockholm, Sweden

    Postdoctoral – Skeletal Muscle Progenitors

    Katholieke Universiteit Leuven – Leuven, Belgium

    Assistant/Associate Faculty Position – Cancer Research

    University of Colorado Denver – Aurora, Colorado, United States

    > See All Jobs

    Submit (1)
    Brought to you by
    stemcell-logo-for newsletter-2
    Muscle Cell News Twitter